Genprex

Tagged: Johns Hopkins Medicine

Genprex’s Non-Viral Delivery System Once Again Ahead of Recent Industry Research

Researchers at Johns Hopkins Medicine recently published a study in Science Advances that introduces a non-viral delivery system for gene editing. Genprex has already treated more than 50 patients in Phase I and II clinical trials using its proprietary non-viral delivery system.

Read More